CA Stock MarketDetailed Quotes

PREV PreveCeutical Medical Inc

Watchlist
  • 0.025
  • 0.0000.00%
15min DelayMarket Closed Jan 3 15:51 ET
13.54MMarket Cap-12.50P/E (TTM)

PreveCeutical Medical Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
57.71%241.49K
69.50%275.54K
-51.79%142.11K
-9.04%963.12K
54.31%352.7K
-69.09%153.12K
-6.46%162.56K
83.00%294.74K
17.93%1.06M
-21.01%228.57K
Selling and administrative expenses
109.04%183.26K
97.15%198.05K
-64.67%82.42K
-14.64%711.66K
70.01%290.26K
-80.30%87.67K
-6.29%100.46K
110.56%233.28K
26.71%833.71K
-21.80%170.73K
-General and administrative expense
109.04%183.26K
97.15%198.05K
-64.67%82.42K
-14.64%711.66K
70.01%290.26K
-80.30%87.67K
-6.29%100.46K
110.56%233.28K
26.71%833.71K
-21.80%170.73K
Research and development costs
-15.05%44.5K
9.99%50.01K
-3.48%45.61K
26.33%193.81K
20.96%48.72K
32.40%52.38K
29.38%45.46K
22.91%47.25K
-10.72%153.42K
-33.09%40.28K
Depreciation amortization depletion
4.27%2.54K
1.65%2.52K
0.40%2.5K
-0.35%9.86K
-62.73%2.45K
124.31%2.44K
124.52%2.48K
121.05%2.49K
94.28%9.89K
836.47%6.57K
-Depreciation and amortization
4.27%2.54K
1.65%2.52K
0.40%2.5K
-0.35%9.86K
-62.73%2.45K
124.31%2.44K
124.52%2.48K
121.05%2.49K
94.28%9.89K
836.47%6.57K
Other operating expenses
5.15%11.19K
76.29%24.96K
-1.19%11.58K
-22.66%47.79K
2.55%11.27K
9.12%10.64K
-53.34%14.16K
9.53%11.72K
-1.80%61.79K
8.44%10.99K
Operating profit
-57.71%-241.49K
-69.50%-275.54K
51.79%-142.11K
9.04%-963.12K
-54.31%-352.7K
69.09%-153.12K
6.46%-162.56K
-83.00%-294.74K
-17.93%-1.06M
21.01%-228.57K
Net non-operating interest income (expenses)
-3.36%-82.39K
-6.71%-81.93K
-10.33%-80.94K
-30.45%-309.53K
-128.10%-79.69K
73.25%-79.71K
9.42%-76.78K
46.88%-73.36K
49.18%-237.27K
268.70%283.62K
Non-operating interest expense
3.36%82.39K
6.71%81.93K
10.33%80.94K
30.45%309.53K
128.10%79.69K
-73.25%79.71K
-9.42%76.78K
-46.88%73.36K
-49.18%237.27K
-268.70%-283.62K
Other net income (expenses)
-74.45%-11.87K
-151.31%-4.49K
5.61%-12.35K
99.02%-1.82K
-96.66%9.31K
-63.72%-6.81K
105.54%8.76K
95.67%-13.08K
51.54%-185.28K
966.78%278.84K
Gain on sale of security
-74.45%-11.87K
-151.31%-4.49K
5.61%-12.35K
-28.30%-1.82K
-97.07%9.31K
-63.72%-6.81K
105.54%8.76K
91.66%-13.08K
99.33%-1.42K
1,154.09%317.65K
Special income (charges)
----
----
----
--0
----
----
----
----
-8.37%-183.86K
-1,808.31%-38.82K
-Less:Other special charges
----
----
----
----
----
----
----
----
-12.61%145.83K
--0
-Less:Write off
----
----
----
--0
----
----
----
----
--38.82K
----
-Gain on sale of property,plant,equipment
----
----
----
--0
----
----
----
----
128.40%789
--0
Income before tax
-40.11%-335.75K
-56.98%-361.96K
38.25%-235.4K
13.97%-1.27M
-226.71%-423.07K
69.95%-239.64K
44.65%-230.58K
36.58%-381.19K
15.21%-1.48M
168.19%333.89K
Income tax
Earnings from equity interest net of tax
Net income
-40.11%-335.75K
-56.98%-361.96K
38.25%-235.4K
13.97%-1.27M
-226.71%-423.07K
69.95%-239.64K
44.65%-230.58K
36.58%-381.19K
14.20%-1.48M
171.16%333.89K
Net income continuous operations
-40.11%-335.75K
-56.98%-361.96K
38.25%-235.4K
13.97%-1.27M
-226.71%-423.07K
69.95%-239.64K
44.65%-230.58K
36.58%-381.19K
14.20%-1.48M
171.16%333.89K
Noncontrolling interests
Net income attributable to the company
-40.11%-335.75K
-56.98%-361.96K
38.25%-235.4K
13.97%-1.27M
-226.71%-423.07K
69.95%-239.64K
44.65%-230.58K
36.58%-381.19K
14.20%-1.48M
171.16%333.89K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-40.11%-335.75K
-56.98%-361.96K
38.25%-235.4K
13.97%-1.27M
-226.71%-423.07K
69.95%-239.64K
44.65%-230.58K
36.58%-381.19K
14.20%-1.48M
171.16%333.89K
Diluted earnings per share
-123.21%-0.001
-132.02%-0.001
56.00%-0.0004
33.33%-0.002
0
77.60%-0.0004
45.85%-0.0004
-11.11%-0.001
0.00%-0.003
0
Basic earnings per share
-123.21%-0.001
-132.02%-0.001
56.00%-0.0004
33.33%-0.002
0
77.60%-0.0004
45.85%-0.0004
-11.11%-0.001
0.00%-0.003
0
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 57.71%241.49K69.50%275.54K-51.79%142.11K-9.04%963.12K54.31%352.7K-69.09%153.12K-6.46%162.56K83.00%294.74K17.93%1.06M-21.01%228.57K
Selling and administrative expenses 109.04%183.26K97.15%198.05K-64.67%82.42K-14.64%711.66K70.01%290.26K-80.30%87.67K-6.29%100.46K110.56%233.28K26.71%833.71K-21.80%170.73K
-General and administrative expense 109.04%183.26K97.15%198.05K-64.67%82.42K-14.64%711.66K70.01%290.26K-80.30%87.67K-6.29%100.46K110.56%233.28K26.71%833.71K-21.80%170.73K
Research and development costs -15.05%44.5K9.99%50.01K-3.48%45.61K26.33%193.81K20.96%48.72K32.40%52.38K29.38%45.46K22.91%47.25K-10.72%153.42K-33.09%40.28K
Depreciation amortization depletion 4.27%2.54K1.65%2.52K0.40%2.5K-0.35%9.86K-62.73%2.45K124.31%2.44K124.52%2.48K121.05%2.49K94.28%9.89K836.47%6.57K
-Depreciation and amortization 4.27%2.54K1.65%2.52K0.40%2.5K-0.35%9.86K-62.73%2.45K124.31%2.44K124.52%2.48K121.05%2.49K94.28%9.89K836.47%6.57K
Other operating expenses 5.15%11.19K76.29%24.96K-1.19%11.58K-22.66%47.79K2.55%11.27K9.12%10.64K-53.34%14.16K9.53%11.72K-1.80%61.79K8.44%10.99K
Operating profit -57.71%-241.49K-69.50%-275.54K51.79%-142.11K9.04%-963.12K-54.31%-352.7K69.09%-153.12K6.46%-162.56K-83.00%-294.74K-17.93%-1.06M21.01%-228.57K
Net non-operating interest income (expenses) -3.36%-82.39K-6.71%-81.93K-10.33%-80.94K-30.45%-309.53K-128.10%-79.69K73.25%-79.71K9.42%-76.78K46.88%-73.36K49.18%-237.27K268.70%283.62K
Non-operating interest expense 3.36%82.39K6.71%81.93K10.33%80.94K30.45%309.53K128.10%79.69K-73.25%79.71K-9.42%76.78K-46.88%73.36K-49.18%237.27K-268.70%-283.62K
Other net income (expenses) -74.45%-11.87K-151.31%-4.49K5.61%-12.35K99.02%-1.82K-96.66%9.31K-63.72%-6.81K105.54%8.76K95.67%-13.08K51.54%-185.28K966.78%278.84K
Gain on sale of security -74.45%-11.87K-151.31%-4.49K5.61%-12.35K-28.30%-1.82K-97.07%9.31K-63.72%-6.81K105.54%8.76K91.66%-13.08K99.33%-1.42K1,154.09%317.65K
Special income (charges) --------------0-----------------8.37%-183.86K-1,808.31%-38.82K
-Less:Other special charges ---------------------------------12.61%145.83K--0
-Less:Write off --------------0------------------38.82K----
-Gain on sale of property,plant,equipment --------------0----------------128.40%789--0
Income before tax -40.11%-335.75K-56.98%-361.96K38.25%-235.4K13.97%-1.27M-226.71%-423.07K69.95%-239.64K44.65%-230.58K36.58%-381.19K15.21%-1.48M168.19%333.89K
Income tax
Earnings from equity interest net of tax
Net income -40.11%-335.75K-56.98%-361.96K38.25%-235.4K13.97%-1.27M-226.71%-423.07K69.95%-239.64K44.65%-230.58K36.58%-381.19K14.20%-1.48M171.16%333.89K
Net income continuous operations -40.11%-335.75K-56.98%-361.96K38.25%-235.4K13.97%-1.27M-226.71%-423.07K69.95%-239.64K44.65%-230.58K36.58%-381.19K14.20%-1.48M171.16%333.89K
Noncontrolling interests
Net income attributable to the company -40.11%-335.75K-56.98%-361.96K38.25%-235.4K13.97%-1.27M-226.71%-423.07K69.95%-239.64K44.65%-230.58K36.58%-381.19K14.20%-1.48M171.16%333.89K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -40.11%-335.75K-56.98%-361.96K38.25%-235.4K13.97%-1.27M-226.71%-423.07K69.95%-239.64K44.65%-230.58K36.58%-381.19K14.20%-1.48M171.16%333.89K
Diluted earnings per share -123.21%-0.001-132.02%-0.00156.00%-0.000433.33%-0.002077.60%-0.000445.85%-0.0004-11.11%-0.0010.00%-0.0030
Basic earnings per share -123.21%-0.001-132.02%-0.00156.00%-0.000433.33%-0.002077.60%-0.000445.85%-0.0004-11.11%-0.0010.00%-0.0030
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.